Cardiovascular Risk Plummets After Weight-Loss Surgery

The Roux-en-Y procedure significantly lowers risk of heart attack, stroke and kidney disease in individuals struggling with obesity and diabetes.

By
estaff
-
Published:
0
In a sleeve gastrectomy (SG, left), about 75% of the stomach is removed, leaving a small tube, or sleeve that holds less food. In the Roux-en-Y gastric bypass (RYGB, right), the surgeon divides the stomach and connects a small piece to the lower part of the small intestine, bypassing the upper intestine. Both procedures lower CVD risk better than nonsurgical treatments, but the RYGB is more effective and produces more durable weight loss and blood sugar control, as well.

More than 10 randomized clinical trials have shown that bariatric surgery—also called weight-loss surgery or metabolic surgery—improves diabetes control and cardiovascular disease (CVD) risk factors better than the best medications in individuals with obesity and type 2 diabetes mellitus (T2DM).

To continue reading this article or issue you must be a paid subscriber. Sign in
Subscribe

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access

RELATED ARTICLESMORE FROM AUTHOR